TrialJournal of nephrology2019

Control of metabolic predisposition to cardiovascular complications of chronic kidney disease by effervescent calcium magnesium citrate: a feasibility study.

Henry Quiñones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.